Triamcinolone
This corticosteroid medication reduces inflammation and immune activity and is used to treat a wide range of conditions including asthma, allergic reactions, skin conditions like eczema and psoriasis, and joint inflammation from arthritis. It is available in multiple forms including inhalers, skin creams, nasal sprays, and injections directly into joints or lesions. Long-term or widespread use can cause side effects including thinning skin, elevated blood sugar, and adrenal suppression.
Molecular Weight
394.4000 g/mol
LogP
1.20
TPSA
115.00 Ų
Lipinski RO5
Pass
Therapeutic Areas
Pharmacokinetics (PK)
Pharmacodynamics (PD)
2D Structure
Cite this structure
Embed this structure
SMILES
C[C@]12C=CC(=O)C=C1CC[C@H]1[C@@H]3C[C@@H](O)[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@]12F
InChI
InChI=1S/C21H27FO6/c1-18-6-5-12(24)7-11(18)3-4-13-14-8-15(25)21(28,17(27)10-23)19(14,2)9-16(26)20(13,18)22/h5-7,13-16,23,25-26,28H,3-4,8-10H2,1-2H3/t13-,14-,15+,16-,18-,19-,20-,21-/m0/s1
Molecular Formula
C21H27FO6
HBD / HBA
4 / 7
Rotatable Bonds
2
Heavy Atoms
28
No targets recorded
Target interaction data is not yet available for this drug.
No interactions recorded
Drug interaction data is not yet available for this compound.
No side effects recorded
Side effect data is not yet available for this drug.
Frequently Asked Questions
This corticosteroid medication reduces inflammation and immune activity and is used to treat a wide range of conditions including asthma, allergic reactions, skin conditions like eczema and psoriasis, and joint inflammation from arthritis. It is available in multiple forms including inhalers, skin creams, nasal sprays, and injections directly into joints or lesions. Long-term or widespread use can cause side effects including thinning skin, elevated blood sugar, and adrenal suppression.
Yes, Triamcinolone is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.
References & Data Sources
- ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1451. Open-access bioactivity database.
- PubChem — National Center for Biotechnology Information (NCBI). CID 31307. Chemical information database.
Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.
Embed This Widget
Add the script tag and a data attribute to embed this widget.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<div data-drugfyi="drug" data-slug="triamcinolone"></div>Embed via iframe for maximum compatibility.
<iframe src="https://drugfyi.com/iframe/drug/triamcinolone/" width="420" height="400" frameborder="0" style="border:0;border-radius:10px;max-width:100%" loading="lazy"></iframe>Paste this URL in WordPress, Medium, or any oEmbed-compatible platform.
https://drugfyi.com/drug/triamcinolone/Add a dynamic SVG badge to your README or docs.
[](https://drugfyi.com/drug/triamcinolone/)Use the native HTML custom element.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<drugfyi-drug slug="triamcinolone"></drugfyi-drug>